Clinical Trials Browser

Phase 2/3 × Cyproterone acetate, ethinyl estradiol drug combination × Clear all

NCT05316935 2025-08-11

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Phase 2/3 Recruiting

Progesterone Resistance, Endometrial Hyperplasia, Endometrial Neoplasms